XML 38 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
Earnings Per Share
9 Months Ended
Sep. 30, 2016
Earnings Per Share [Abstract]  
Earnings Per Share
Earnings Per Share

The following table summarizes the Company’s computation of basic and diluted earnings per share (EPS) for the three and nine months ended September 30, 2016 and 2015 (amounts in thousands except per share information):
 
Three Months Ended September 30, 2016
 
Nine Months Ended September 30, 2016
 
Income
(numerator)
 
Shares
(denominator)
 
Per Share
Amount
 
Income
(numerator)
 
Shares
(denominator)
 
Per Share
Amount
Basic EPS:
 
 
 
 
 
 
 
 
 
 
 
Income from continuing operations
$
57,526

 
 
 
 
 
$
166,841

 
 
 
 
Less: preferred dividend requirements
(5,951
)
 
 
 
 
 
(17,855
)
 
 
 
 
Net income available to common shareholders
$
51,575

 
63,627

 
$
0.81

 
$
148,986

 
63,296

 
$
2.35

Diluted EPS:
 
 
 
 
 
 
 
 
 
 
 
Income from continuing operations available to common shareholders
$
51,575

 
63,627

 
 
 
$
148,986

 
63,296

 
 
Effect of dilutive securities:
 
 
 
 
 
 
 
 
 
 
 
Share options

 
120

 
 
 

 
97

 
 
Net income available to common shareholders
$
51,575

 
63,747

 
$
0.81

 
$
148,986

 
63,393

 
$
2.35


 
Three Months Ended September 30, 2015
 
Nine Months Ended September 30, 2015
 
Income
(numerator)
 
Shares
(denominator)
 
Per Share
Amount
 
Income
(numerator)
 
Shares
(denominator)
 
Per Share
Amount
Basic EPS:
 
 
 
 
 
 
 
 
 
 
 
Income from continuing operations
$
50,054

 
 
 
 
 
$
141,583

 
 
 
 
Less: preferred dividend requirements
(5,951
)
 
 
 
 
 
(17,855
)
 
 
 
 
Income from continuing operations available to common shareholders
$
44,103

 
58,083

 
$
0.76

 
$
123,728

 
57,468

 
$
2.15

Income from discontinued operations available to common shareholders
$
141

 
58,083

 
$

 
$
199

 
57,468

 
$

Net income available to common shareholders
$
44,244

 
58,083

 
$
0.76

 
$
123,927

 
57,468

 
$
2.15

Diluted EPS:
 
 
 
 
 
 
 
 
 
 
 
Income from continuing operations available to common shareholders
$
44,103

 
58,083

 
 
 
$
123,728

 
57,468

 
 
Effect of dilutive securities:
 
 
 
 
 
 
 
 
 
 
 
Share options

 
195

 
 
 

 
231

 
 
Income from continuing operations available to common shareholders
$
44,103

 
58,278

 
$
0.76

 
$
123,728

 
57,699

 
$
2.15

Income from discontinued operations available to common shareholders
$
141

 
58,278

 
$

 
$
199

 
57,699

 
$

Net income available to common shareholders
$
44,244

 
58,278

 
$
0.76

 
$
123,927

 
57,699

 
$
2.15

 
 
 
 
 
 
 
 
 
 
 
 


The additional 2.0 million common shares that would result from the conversion of the Company’s 5.75% Series C cumulative convertible preferred shares and the additional 1.6 million common shares that would result from the conversion of the Company’s 9.0% Series E cumulative convertible preferred shares and the corresponding add-back of the preferred dividends declared on those shares are not included in the calculation of diluted earnings per share for the three and nine months ended September 30, 2016 and 2015 because the effect is anti-dilutive.

The dilutive effect of potential common shares from the exercise of share options is included in diluted earnings per share for the three and nine months ended September 30, 2016 and 2015. For the three months ended September 30, 2015, options to purchase 323 thousand shares of common shares per share prices ranging from $46.86 to $65.50, were not included in the computation of diluted earnings per share because the options were anti-dilutive. For the three months ended September 30, 2016, there were no anti-dilutive options. For the nine months ended September 30, 2016 and 2015, options to purchase 84 thousand and 315 thousand shares of common shares, respectively, at a per share price of $61.79 for the nine months ended September 30, 2016 and per share prices ranging from $51.64 to $65.50 for the nine months ended September 30, 2015, were not included in the computation of diluted earnings per share because the options were anti-dilutive.